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Pathogenetics encompasses studying the various factors and
different mechanisms involved in the pathogenesis of genetic
diseases. It comprises the study of mutagens or factors that
can cause change and/or damage of the genetic material, the
study of mutations or acquired structural/functional changes
of the genetic components at any of its organizational levels
that result secondary to the effects of mutagens, the study of
the various anti-mutation mechanisms of the human genome/
transcriptome/proteome that exert an essential and pivotal role
in maintaining the integrity/stability/identity of the genome, the
study of the different and varying pathophysiological alterations
in cellular functions secondary to the ensuing disturbances of
the metabolic-regulatory networks that mediate and control
these functions, and the study of the different pathogenetic
mechanisms that mediate the development and pathogenesis
of genetic defects due to the ensuing changes of the normal
structure/function framework of the genetic material.
2. Pathogenesis of genetic diseases
Genetic diseases are caused by harmful mutations. Mutations
cause structural changes and consequent functional alterations
of the affected components of the genetic material, leadingultimately to a deﬁcient synthesis of proteins or synthesis of
defective proteins necessary for mediation of cellular activities.
These functional consequences are reﬂected in disturbed/defec-
tive construction of one or more of the metabolic networks that
regulate every aspect of cellular functions. As depicted from the
cardinal dogmaofmolecular biology,mutated genome results in
the transcription of altered transcriptome which, in turn, causes
synthesis of a defective proteome. The defective proteome leads
to wide spread pathophysiological alterations that pave the way
for the development of various pathogenetic mechanisms
responsible for initiation and pathogenesis of genetic disorders.
The spectrum of pathophysiological alterations and patho-
genetic mechanisms is quite wide and is steadily expanding as
more knowledge of the structure/function/behavior/regulation
of the geneticmaterial is revealed.However, the basic etiological
outline of development of genetic defects, as depicted in Fig. 1,
can be summarized as follows (Fig. 1):
(1) Deletion or loss of part of a gene, one or many genes,
part of a chromosome, one or more chromosomes, one
or more of mitochondrial genes, or even a whole genome.
(2) Duplication/rearrangement of the genetic material.
(3) Deﬁcient/defective transcription of mRNA.
(4) Deﬁcient/defective post-transcriptional modiﬁcations of
mRNA.
Figure 1 Pathogenesis of genetic diseases.
Pathogenetics 3(5) Deﬁcient/defective translation of mRNA leading to
deﬁcient/defective production of gene products.
(6) Deﬁcient/defective post-translational modiﬁcations/
trafﬁcking of synthesized proteins.
(7) Deﬁcient/defective synthesis of genetic regulatory
components that include transcription nucleoproteins,
transcription factors, microRNA, etc.
Irrespective of the site, type, nature or magnitude of the
mutational event(s) that drastically affect the genetic material,
the resultant alterations in gene function(s) trigger many dis-
turbances in one or more of the cellular metabolic regulatory
networks mediated by the deﬁcient/defective gene products,
thus leading to a wide and varied spectrum of pathophysiolog-
ical changes in cellular functions leading, ultimately, to the
development of genetic diseases. The speciﬁc pathognomonic
phenotype that characterizes each genetic disease is primarily
determined by the spectrum of pathophysiological changes in
affected subjects. These, in turn, are determined by the spec-
trum of the mutation-induced damage to the genetic material
in affected patients.
3. Mutagens
Mutagens are factors capable of affecting the structural integ-
rity of the genome. The number of harmful mutagens we are
continually exposed to, and interacting with, in our life, start-
ing with fertilization and ending by death, is innumerable.
However, due to the many lines of defense against the harmful
effects of these factors, represented by the many anti-mutation
mechanisms of the genome and proteome, only a small per-
centage of mutational events can reach a threshold level
beyond which genetic defects can develop.
4. Classiﬁcation of mutagens
(A) According to their nature, mutagens are classiﬁed into
three main categories:
(1) Chemical mutagens: these compounds are
innumerable in the environment and include, for
example, organic compounds, asbestos, insecticides,
herbicides, heavy metals, etc.(2) Physical mutagens: these include particulate radi-
ations like X ray, alpha particles, UV waves at
2800 A˚ wavelength, solar radiation, thermal and
mechanical agitation of nucleic acids [1].
(3) Biological mutagens: these include living microor-
ganisms like some viruses: cytomegalovirus, rub-
ella virus and herpes virus.(B) According to their pathogenetic effects, mutagens are
classiﬁed into four main categories:
(1) Non-speciﬁc Mutagens.
(2) Carcinogens are mutagens that induce malignant
transformations in affected cells.
(3) Clastogens are mutagenic agents that can induce
chromosome breaks in affected cells.
(4) Teratogens are mutagens that cause congenital
malformations in exposed fetuses. (Fig. 2)The pathogenetic effects of mutagens and the resulting
pathological alterations follow disturbed functions of mutated
genes. Many types of mutagens have the ability to induce all
types of mutagenic damage to the cell. Particulate and non-
particulate radiations, for example, are effective carcinogens
capable of causing malignant transformation of affected cells.
They can also cause chromosomal gaps and breaks. In
addition, teratogenic effects in developing fetuses following
exposure of pregnant women to radiation are a well-known
hazard of overexposure to radiation during pregnancy. This
global mutagenic effect is also shared by many other types of
mutagens like mutagenic viruses and chemicals that can induce
malignant transformation, chromosomal breaks and terato-
genic malformations in exposed subjects.5. Factors affecting actions of mutagens
The pathological effects of mutagens are determined by many
different factors. Each of these factors has its relative muta-
genic potential depending on the circumstances of its action.
Congenital malformations caused by teratogens, for instance,
depend largely on timing of exposure of the developing
Figure 2 Classiﬁcations of mutagens.
Table 1 Classiﬁcation of mutation.
Classiﬁcation of mutation
1. Induced versus spontaneous mutation
2. Nuclear versus mitochondrial mutation
3. Somatic versus germinal mutation
4. Static versus dynamic mutation
5. Pathological versus non-pathological mutation
6. Point, Small, Gross, Genomic mutation
7. Base, Sugar, Phosphate group mutation
8. Persistent versus reversible mutation
4 M.S.Z. Salemembryo or growing fetus to their effects. Exposure to terato-
gens before or after periods of embryonic or fetal growth sen-
sitive to their speciﬁc teratogenic effects might result in no or
minimal harm. The dose of exposure, whether of a chemical
or radiological nature, is also an important factor in determin-
ing the resultant mutagenic effects. This dose-threshold effect
might act in different synergistic ways. A larger exposure dose
will quantitatively cause more damage to wider portions of the
genetic material, thus resulting in widespread mutations of the
genome. It might also cause damage to genes responsible for
repair of mutated DNA, thus preventing repair of mutated
genes. In addition, direct non-genetic destructive effects of
cellular compartments, of blood supply to cells or of extracel-
lular environment of affected cells will both hasten and
increase the resulting damage.
The genetic constitution, or genetic background, of exposed
subjects plays a critical role in determining the sensitivity to
mutagenic factors as well as the extent of damage following
exposure to their effects. The outstanding examples in this
respect are the chromosome breakage syndromes, sometimes
referred to as DNA or genetic instability syndromes. These dis-
eases include xeroderma pigmentosum, ataxia telangiectasia,
Nijmegen syndrome, Bloom syndrome, Fanconi anemia and
some other similar diseases. Subjects affected by these genetic
disorders have deﬁcient and/or defective DNA repair systems
necessary for repairing mutations arising during DNA
replication or following exposure to mutagens. Exposure to
mutagenic factors in doses that have no effects in normal
subjects causes drastic genetic alterations in these patients
due to their defective genetic constitution.
6. Mutation
Mutation entails any uncoded or unprogramed permanent
structural alteration of the genetic material at any of its orga-
nizational levels. These levels comprise a spectrum beginning
with single nucleotide or a part of the nucleotide (base, sugar,
phosphate), DNA, RNA, genes, chromosomes, mitochondrial
DNA (mtDNA) up to the whole genome. Mutations may
occur without an identiﬁable cause and are termed sponta-
neous mutations, or they may occur secondary to exposure
to a known cause, and are referred to as induced mutations.The effects of mutation differ widely according to many
factors. These factors include the nature and target of the
mutagenic factor causing mutation, the timing and magnitude
of the resulting damage, the genotype or the genetic constitution
of the affected individual and the balance between synergistic
mutagenic effects and anti-mutation mechanisms of the genetic
material. The damaging effects of mutation are attributed to
the defects they cause in functioning of the mutated genes.
Since synthesis of proper gene products, necessary for mediating
cellular activities, depends primarily on the integrity of the
genetic information embodied within the speciﬁc base sequence
of the gene, changes or mutation of the exact number or
the peculiar arrangement of these bases is expected to result
in disturbed gene function. This disturbance might express
itself as production of structurally defective gene product,
deﬁcient synthesis of enough product or disturbances in the
construction of regulatory/metabolic networks responsible for
monitoring, harmonizing and controlling cellular functions.
7. Classiﬁcation of mutation
(1) Induced vs spontaneous mutation
(2) Nuclear vs mitochondrial mutation
(3) Somatic vs germinal mutation
(4) Static vs dynamic mutation
(5) Pathological vs non-pathological mutation
(6) Point, small, gross and genomic mutation
(7) Base, sugar, phosphate group mutation
(8) Persistent vs reversible mutation [Table 1].
Pathogenetics 57.1. Induced and spontaneous mutation
Induced mutations are structural alterations of the genetic
material that occur due to exposure to the effects of any of
the known mutagens. Spontaneous mutations, on the other
hand, are mutations that occur without recognizable causes.
Spontaneous mutations happen, probably, on a regular basis
because of the intrinsic nature of the genome. Possible poten-
tial causes of spontaneous mutation of the genome can be
delineated and include: transposon activity, tautomerism and
changes of energy states of hydrogen bonds of bases.
Transposon activity represents a major potential cause of
spontaneous mutations [2]. The movement of transposons
results in insertional mutagenesis and disruption of targeted
genes or other functional genetic elements. Disturbed gene
function with resultant deﬁciency of gene product, production
of defective protein/RNA or loss of genetic regulatory mecha-
nisms exerted by mutated genes follows transposon-induced
mutations. Tautomerism of bases of the DNA also accounts
for a considerable fraction of spontaneous mutations of the
genetic material. Changes of energy states of hydrogen bonds
between complementary bases of DNA represent a third
potential cause of spontaneous mutation. Alterations resulting
from changes in electron resonance and/or proton transfer or
relocation between the bonds can lead to tautomeric shift or
tautomerization and momentary change of one base to
another base, thus inducing point mutation, transition muta-
tion [1]. The actual mechanisms underlying the occurrence of
these changes are still largely undeﬁned, precisely. Analysis
of DNA base dynamics according to quantum, rather than
to Newtonian, principles seems essential for clarifying these
mechanisms, and the concept of quantum biology, or studying
the structure and function of the genetic material based on
principles and rules of quantum mechanics, would certainly
prevail due to the progressive increase in our knowledge of
the structure and function(s) of our genome and our proteome.
Replicative errors occurring during cell division and repli-
cation of the DNA are, arbitrarily, considered as one source
of spontaneous mutations. These errors occur, and persist,
due to many causes including failure of the proof reading sys-
tem of DNA replication or failure of the DNA repair system to
repair or correct the errors. It is estimated that during every
somatic cell division cycle of nearly 20 h duration, about
12,000 point mutations occur along the whole genome. The
vast majority of these replicative errors are repaired by the
DNA repair system of the cell. If some of these errors escape
detection and repair they will persist and be transferred to
the genome of daughter cells and become ﬁxed mutations.
7.2. Nuclear and mitochondrial mutation
Nuclear mutations are mutations that affect the nuclear gen-
ome, and mitochondrial mutations are mutations that affect
the mitochondrial genome. Mutations of nuclear genes
account for the occurrence of most genetic diseases. Due to
the marked differences between the speciﬁc structural organi-
zation of each genome, each type of these mutations has its
own characteristic features. Nuclear mutations may affect
one or both alleles of a structural gene on an autosome or
on a sex chromosome, thus giving rise to any of the traditional
genetic disorders: autosomal and sex linked dominant andrecessive diseases. The presence of most nuclear genes as pairs
of alleles derived equally from both parents, paternal and
maternal alleles, allows for this classiﬁcation of genetic dis-
eases due to nuclear gene mutations to be formulated clearly.
Mitochondrial mutations, on the other hand, have different
features due to the peculiar nature of the mtDNA. Each
mtDNA molecule consists of 37 genes and exists inside the
mitochondrion in large numbers, tens to thousands, depending
on the metabolic activities of the cell and its demand for ATP.
Thus, the copy number of each mtDNA molecule, and of
mitochondrial genes is extremely huge in metabolically active
organs, e.g. brain, retina, heart, liver, kidney and skeletal
muscles. Mutations of mitochondrial genome can affect a
considerable portion of its genes without affecting its efﬁciency
in mediating its functions. It is estimated that mitochondrial
dysfunction begins to occur when approximately 80% of its
genome gets mutated. This threshold effect does not apply
for nuclear mutations where mutation of one single allele
can cause a serious disease, as is the case for many autosomal
dominant disorders.
Mitochondria in somatic cells are derived from maternal
mitochondria in the ovum. The sperm, with rare exceptions,
does not offer any mitochondrial genes to the zygote, because
sperm mitochondria are present in the neck piece of the sperm,
which exists next to its head pro-nucleus and which do not par-
ticipate in fertilization. Accordingly, mitochondrial disorders
result from mutations of maternal mitochondria and are trans-
mitted by carrier or affected mothers to all their offspring. This
difference underlies the speciﬁc features that characterize the
nature and the inheritance pattern of mitochondrial diseases.7.3. Somatic and germinal mutation
Somatic mutations refer to mutations of the genome of
somatic cells. Since somatic cells do not participate in fertiliza-
tion or determination of the genetic constitution of the off-
spring they can’t be transmitted to the offspring, i.e. they are
not heritable mutations. They can be transmitted only to the
daughter cells of mutated cells upon their division. The effects
of somatic mutations depend on many factors including the
type of cell, the genetic constitution of affected cells, selective
targeting of nuclear and/or mitochondrial genome and the
mutation burden of the cell. According to the interactive pro-
cesses involving these factors, somatic mutations might result
in cell death if the mutation-induced pathophysiological alter-
ations of the cell exceed its ability to obviate and correct these
alterations. Milder alterations can cause deranged cellular
function(s) and limited or progressive failure and loss of cellu-
lar activities, e.g. progressive organ failure syndrome following
overexposure to radiation. Somatic mutations affecting the
proto-oncogenes or genes regulating DNA repair systems
can result in malignant transformation of the cell and develop-
ment of cancer.
Somatic cells overburdened with mutation are driven to a
special suicidal pathway involving its involuntary death to
protect other cells from the hazardous risk of its malignant
transformation. It might also be looked at as a cellular
economic adaptation behavior by getting rid of mutated
diseased, energy consuming and harmful cells. This mechanism
of compulsory involuntary or programed cell death, referred to
as apoptosis, represents an important protective anti-mutation
Figure 3 Triplet repeat expansion in fragile X syndrome.
6 M.S.Z. Salemmechanism of the organism to maintain its genomic integrity,
and demonstrates one of the basic conservative features of liv-
ing organisms by executing over mutated cells to prevent
spread of their mutations through division to daughter
generations.
Germinal mutations are mutations that affect genomes of
germ line cells, i.e. ova and sperms, that participate in fertiliza-
tion and determination of the genetic constitution of the off-
spring. If the particular ovum or sperm affected by the
mutation happens to participate in fertilization and zygote for-
mation, the mutation will be inherited and transferred to all
cells the offspring and a carrier or disease state might result
according to the nature of the mutated gene and the pattern
of its inheritance.7.4. Static and dynamic mutation
Static mutations signify mutations that are transmitted with-
out change in type or extent of the mutation from a parent
to his progeny. For instance, a father suffering from Marfan
syndrome due to a speciﬁc mutation in the ﬁbrillin gene may
transfer the mutation as it is to some of his offspring.
Mutation analysis by molecular diagnostic techniques of the
gene of both father and child will reveal identity of the muta-
tion between them in the affected gene. Static mutations char-
acterize the mutational events that underlie the development of
most currently deﬁned genetic diseases.
Dynamic mutations, on the other hand, represent a peculiar
category of genetic mutations that increase in magnitude or
extent upon transmission from a carrier parent to an offspring.
The discovery of this type of mutation clariﬁed the patho-
genetic mechanisms responsible for the pathogenesis of a large
number of genetic diseases known as triplet repeat expansion
disorders. The list of these diseases due to this type of mutation
is expanding progressively and includes many common and
relevant genetic disorders like fragile X syndrome, Friedreich
ataxia, Huntington disease, myotonic dystrophy, some types
of spino-cerebellar ataxia and many others.
In this type of mutation, a normal deﬁned number of
codons, triplets of nucleotides, along a speciﬁc segment of
the gene increases in number when the gene is inherited. A
threshold effect characterizes this dynamic mutational process.
Within a certain range, we can identify a normal repeat num-
ber in the normal gene, a larger repeat number in carriers or
pre-mutation state and a much larger number in affected
patients. For instance, the fragile X mental retardation gene
(FMR1 gene) which is mutated in fragile X syndrome, regu-
lates the synthesis of a protein, fragile X mental retardation
protein (FMRP) which acts, partly, as RNA binding protein
that regulates in a global fashion cellular protein translation
and micoRNA regulatory pathways, and has important func-
tions in many organs like the nervous system and the ovaries.
The normal transcript of the gene has a sequence consisting of
six to forty-ﬁve (6–45) repeats of CGG nucleotides at the 50-
untranslated region. Carrier mothers have a larger number
of these repeats ranging from 55–200 repeats. When this per-
mutation state of the gene is transmitted to a male offspring,
progressive increase, or dynamic expansion of the number of
the repeats happens and the gene in the affected male off-
spring, or full mutation state, is found to contain more than
200, sometimes much more numbers up to hundreds, of theserepeats. The deleterious effects of this mutation and the result-
ing pathological phenotypes of the disease are due to disrup-
tion of functions of the FMR1 gene via silencing of the gene
activity and cessation of synthesis of the FMRP, or through
disrupting the structure of the gene leading to production of
a defective protein that can’t mediate its global cellular physi-
ological regulatory functions in post-translation modiﬁcations
and targeting of synthesized proteins (Fig. 3).
7.5. Pathological and non-pathological mutation
The deleterious effects of mutation are determined by many
factors. Mutations affecting functional elements of the gen-
ome, i.e. functional genes, can result in gene dysfunction caus-
ing deﬁcient synthesis of the gene product or synthesis of
defective product. These mutations are expected to cause
pathophysiological changes and disease phenotypes in affected
individuals, and represent an overt example of harmful patho-
logical disease causing mutations. On the other hand, muta-
tions affecting non-functional regions of the genome, e.g.
intergenic areas of DNA and intronic segments of genes, do
not result in pathophysiological alterations and are referred
to as non-pathological mutations.
Though the vast majority of mutational events of the gen-
ome are harmful, some mutations, conversely, have beneﬁcial
effects. Such mutations, known as beneﬁcial mutations, exert
their effects by conferring selective advantage on affected cells
secondary to the resulting change of the structure and function
of protein/enzyme product of the mutated gene. The most
obvious example of beneﬁcial mutations is the sickle mutation
of the b-globin gene. Carriers, but not homozygotes, of this
mutation have a selective value because they are more resistant
to infestation by the malaria parasite compared to normal
subjects. Another example of beneﬁcial mutations is the dele-
tion mutation of the human CCR5 or CD195 or chemokine
receptor type 5. The protein of the normal gene acts as a T cell
membrane receptor and is used by human immunodeﬁciency
virus (HIV) as a gate to enter the cell and build up infection
with the virus. Mutation of the CCR5 gene, CCR5 Delta32
deletion, results in the synthesis of an altered protein that loses
its receptor function and can’t bind the HIV. Carriers of this
beneﬁcial mutation are resistant to infection and genetic
homozygosity of the mutation is known to confer protection
against infection with the virus [3].
7.6. Point, small, gross and genomic mutation
Mutations are arbitrarily classiﬁed according to the size of
affected component or region of the genome and the magni-
tude of the mutational damage into point, small, gross and
Figure 4 Types & molecular mechanisms of point mutation.
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single base of the gene irrespective of the size of the gene.
Small mutations involve larger mutations of many bases, one
or more exons or introns and one or more genes. Gross muta-
tions comprise chromosomal abnormalities where tens, or even
hundreds, of genes are affected by deletion/inversion/transloca
tion of even tiny pieces of affected chromosomes. Genomic
mutations represent the extreme end of the spectrum of muta-
tions where the whole genome undergoes mutational changes.
Triploidy and tetraploidy represent rare examples of structural
or numerical genomic mutations. Also, aberrant development
of vesicular moles and dermoid cysts represents clear examples
of functional genomic mutations due to disordered imprinting
of the whole haploid genome of the germinal cells following
fertilization.
7.6.1. Molecular mechanisms of point mutation
Point mutations refer to mutational events that involve one
single base of the gene irrespective of the size of the gene.
Lethal genetic diseases can be caused by single point muta-
tions, even in very large genes. A well known example is
Duchenne myopathy due to single point mutations of the dys-
trophin gene which is the largest human gene composed of 2.4
million bases. Sickle cell anemia is another example of a drastic
genetic disease resulting from a single point mutation of the
beta globin gene. Point mutations account for nearly 70% of
currently deﬁned human single gene disorders.
Molecular mechanisms of point mutation comprise a wide
spectrum of alterations at the molecular level of the genetic
material (Fig. 4). These mechanisms include replacement of
one base (nucleotide) of the gene by another base, deletion,
or loss, of one base of the gene and addition of one base to
the gene. Replacement of one base by another base may not
affect the function of the gene or, on the other hand, can have
drastic effects on gene function according to the type and func-
tional consequences of the change.
7.6.2. Types of point mutations
Five different types of point mutation can be delineated: same-
sense, missense, non-sense, re-sense and frame shift point
mutations.7.6.2.1. Same-sense mutation. Due to degeneracy of the genetic
code that allows for deﬁning the same amino acid by different
codons, a point mutation might involve one base of a speciﬁc
codon changing it to another codon, that still deﬁnes the same
amino acid. For example, the amino acid leucine is deﬁned or
dictated by six different codons, TTA–TTG–CTT–CTC–CT
A–CTG. Replacement of one base of some of these codons,
TTA to TTG, CTT to CTC or CTA to CTG, by another base
does not change the speciﬁed amino acid, leucine, in the syn-
thesized protein, hence the term same-sense because the same
amino acid is dictated by the new codon and no change in
the synthesized protein results.
7.6.2.2. Mis-sense mutation. Due to the rigid rules of the
genetic code, a change of one base of a codon might turn it
into another codon that deﬁnes a different amino acid in the
synthesized protein. If base replacement results in a new codon
that speciﬁes a different amino acid, a mis-sense mutation
results. For instance, a point mutation of the codon (TTT)
or (thymine–thymine–thymine) that deﬁnes phenylalanine
may change it to another codon (TCT) or (thymine–cyto
sine–thymine) that deﬁnes serine. For protein translation sys-
tem this change is considered as wrong code, hence the term
missense, since it dictates a different amino acid. The effects
of mis-sense mutation depend on the role played by the origi-
nal amino acid in protein functioning, e.g. protein stability and
aggregation. If it has important roles within fundamental
structural or functional domains of the protein that could
not be performed by the new different amino acid, then patho-
physiological alteration of the structure and/or function of the
protein are expected and the pathogenesis of a genetic defect
might ensue.
7.6.2.3. Non-sense mutation. The sixty-four codons of the
genetic code include three codons that do not deﬁne or dictate
any amino acids and are used by the gene to signal the end of
the protein synthesis process in order to form the proper pro-
tein with the proper number of amino acids. These codons
(TAA–TGA–TAG) are termed stop or termination codons
because they are recognized by both the mRNA transcript
and the translation system as signals or markers of the end
of the translation process since they do not deﬁne any amino
8 M.S.Z. Salemacids, hence the term non-sense, so that no more amino acids
are to be added to the growing polypeptide chain.
Non-sense mutations result when a functional codon deﬁn-
ing a speciﬁc amino acid is changed to a stop or termination
codon. If base replacement results in the formation of a new
stop or termination codon, for instance change of cytosine in
(TAC) codon that deﬁnes tyrosine to adenine turns it to the
stop codon (TAA) resulting in premature cessation of transla-
tion and the production of a short or truncated protein. The
resulting alterations depend on many factors. If the mutation
happens at the beginning of the coding part of the gene, most
of the protein coded by the gene will not be translated from
this point on. A short, or truncated, mostly non-functional
protein will be synthesized and marked deterioration of gene
function might result. If the mutation happens at or near the
end of the coding part of the gene, most of the protein coded
by the gene will be translated and less deterioration, or even no
change, of gene function occurs. In both situations, the result-
ing pathogenetic alterations depend on the physiological role
played by the missing non-translated part or domain of the
protein. If these roles are important in mediating functions
of vital metabolic networks in the cell, then genetic defects will
happen and the pathogenesis of a genetic disorder might ensue.
7.6.2.4. Re-sense mutation. In this type of arbitrarily deﬁned
mutational event, the termination or stop codon at the end
of the last exon of the gene might suffer a point mutation
turning it to a functional codon. In this case, part of the
un-translated region of the mRNA transcript will be included
within the translation process which will continue with
addition of more amino acids, not originally comprised in
the protein sequence, till another stop codon is met with and
recognition of the end signal and cessation of translation
process occurs. The resulting abnormal pathological lengthening
of the polypeptide chain results in the synthesis of a longer and
larger protein. Such abnormal polypeptides are usually
unstable macromolecules that degrade easily or faster than
normal correspondent chains because of defective folding
and improper structural conﬁguration thus leading to quanti-
tative functional deﬁciency. Also, due to their redundancy
and defective primary structure, they might fail to undergo
necessary post-translation modiﬁcations or post-translation
targeting and trafﬁcking to their proper cellular location. In
either condition, genetic disease due to the functional
deﬁciency of the protein might result.Figure 5 Splice s7.6.2.5. Frame-shift mutation. Frame shifting signiﬁes change of
the speciﬁc sequence of the nucleotides of the gene due to dele-
tion or addition of nucleotide(s) followed by corresponding
change of the amino acid sequence of the synthesized protein.
Deletion or addition of one base within the gene will result in
shifting of the reading frame of the newly formed codons.
This type of point mutation is called frame-shift mutation.
The resulting effects may lead to the formation of new same-
sense, missense or stop termination codons with ultimate con-
sequences similar to the results of the similar aforementioned
mechanisms. These same rules apply for mutational events
involving the addition or deletion of two bases. If three bases
are added or deleted, a whole new codon will be added or
removed, respectively. Whereas addition or deletion of one
codon to a functional exon of the gene might result in a wide
spectrum of alterations as previously explained, whole codon
addition or deletion within non-coding parts of the gene,
introns, has no effect on translated protein or on gene function.
Frame shifting of the gene sequence leads to frame shifting in
the amino acid sequence of the synthesized protein and a new
protein with new sequence of amino acids might be translated.
The similarity between the amino acid sequence of the wild type
protein and that of the new protein depends on the start site of
the frame shift mutation of the gene sequence. These same rules
apply for mutational events involving the addition or deletion
of two bases. If three new bases are inserted between existing
codons, however, a whole new codon will be added and an
additional amino acid will be added to the polypeptide chain
of the protein. Also, if three bases constituting a functional
codon are removed or deleted from the gene, the amino acid
speciﬁed by the deleted codon will not be translated and will
be missing from the synthesized polypeptide chain. Whereas
addition or deletion of one codon to a functional exon of the
gene might result in a wide spectrum of alterations as previ-
ously explained, whole codon addition or deletion within
non-coding parts of the gene, e.g. introns, usually has no effect
on translated protein or on gene function [4].
Change in the structure of one base of the gene, e.g. methy-
lation of cytosine, can affect gene transcription through several
different mechanisms. Each cell has a speciﬁc methylation
pattern necessary for normal cell differentiation during
development. Changes in this pattern by mutations of regulatory
genes controlling its timing and its magnitude can have
marked deteriorating effects on the cell during differentiation.
This type of mutation must not be confused with epigeneticite mutations.
Figure 6 Types of chromosomal abnormalities.
Figure 7 Structural chromosomal abnormalities.
Pathogenetics 9mutations that involve structural changes in the chromatin or
the DNA-associated proteins rather than the DNA itself [5].
7.6.3. Small mutations
Small mutations are arbitrarily classiﬁed so as to comprise
structural changes involving more than one base of a gene.
Accordingly, they span a very wide spectrum of pathogenetic
structural alterations of the genetic material beginning with
mutations involving at least two nucleotides and ending with
mutations involving part of a gene, a whole gene or, even,
few genes. Small mutations include addition or removal of
two or more bases, addition or removal of one or more
codons, single or multiple exon deletion or duplication, singleor multiple intron deletion or duplication, deletion or duplica-
tion of a gene or of few genes, ampliﬁcation of genes, inactiva-
tion of genes and transposon-induced mutations.
The pathophysiological consequences of these mutations
depend on the resulting changes in either the genetic regulatory
networks or the metabolic networks of the cell secondary to
deﬁcient and/or defective synthesis of the gene product. The
resulting deterioration of gene function leading to the patho-
genesis of a genetic disorder correlates with the extent of deﬁ-
ciency of the gene product, whether due to actual deﬁciency of
the protein or regulatory small RNA coded by the gene due to
suppression of gene function and inability to synthesize the
gene product, or to relative or absolute deﬁciency of the
10 M.S.Z. Salemfunction of a faulty synthesized gene product. Deletion of large
portions of a gene, multiple exon deletions for instance, result
in the synthesis of grossly defective protein lacking most or
much of its domains needed to mediate its destined physiolog-
ical roles causing marked pathophysiological deteriorations in
the functioning metabolic networks dependent on these roles,
thus predisposing to development of genetic disorders.
Small mutations of bases involved in splisosome mecha-
nisms mediating intron excision and splicing of remaining
exons, as part of the post-transcription modiﬁcations of
mRNA, can have marked effects on the translation efﬁciency
of the ﬁnal mRNA and is a well-known mutational mechanism
that underlies the pathogenesis of many common and serious
genetic diseases (Fig. 5). These splice site mutations may result
in over excision of parts of adjacent exons and synthesis of
shorter polypeptide chains. If the missing amino acids coded
by the over excised parts are important for mediating protein
function or maintaining its structural integrity, then patho-
physiological alterations and pathogenesis of disease might
be expected. On the other hand, if splice site mutations result
in skipping of an intron, part of an intron, a whole intron or
multiple introns from excision, the resulting translated protein
might be large enough to be unstable and easily degradable, or
its structural conﬁguration might be altered in such a way that
its functional domains are no more accessible to each other or
to other components, e.g. substrates or intermediary metabo-
lites, needed for mediating its physiological functions, and a
pathogenetic defect results.7.6.4. Gross mutations
Gross mutations are mutations that involve large portions of
the genetic material. Chromosomal aberrations represent the
prototype of this type of mutation, since even the smallest
functional portion of a chromosome may consist of tens to
hundreds of genes. Due to the peculiar structural organization
of the nuclear human genome, chromosomal abnormalities
can involve either the structure of the chromosome, structural
chromosomal abnormalities or the number of the chromo-
somes, numerical chromosomal abnormalities. Mutations of
chromosome structure might involve the autosomes, autosomal
chromosomal abnormalities, of chromosomes 1–22, or sex
chromosomal abnormalities involving the sex chromosomes
(X and Y chromosomes). Structural chromosomal aberrations
include different pathogenetic types like deletions, duplica-
tions, inversions, ring chromosome formation, unidirectional
translocation, mutual translocations and Robertsonian
translocations, chromosome gaps and breaks, and other less
common abnormal types. Numerical chromosomal abnormal-
ities that affect the number of chromosome encompass
varied group of aberrations including trisomy, monosomy,
hypodiploidy, hyperdiploidy, triploidy and tetraploidy
(Fig. 6) [6].7.6.4.1. Types and molecular mechanisms of chromosomal
aberrations. (1) Structural chromosomal aberrations (Fig. 7).
(a) Deletion
Chromosome deletion means loss of part of the chromo-
some. It may be terminal deletion when it involves the end
piece of the chromosome or interstitial deletion when it affects
other parts of the chromosome. Interstitial deletions involving
the centromeric region of the chromosome lead to formationof acentric chromosomes. Because chromosome segregation
during cell division depends on attachment of the spindle ﬁb-
rils to speciﬁc centromeric receptor proteins, acentric chromo-
somes are lost during the anaphase stage of cell division and
chromosome monosomy of affected daughter cell results.
Autosomal monosomy is incompatible with life of the cell in
view of the deleterious functional deﬁciency of the proteome
due to loss of hundreds, even thousands, of genes located on
the missing chromosome.
(b) Translocation
Translocation involves breakage of part of the chromosome
and its insertion within the genetic material of another
chromosome. It may be unidirectional when a segment of
the chromosome is broken at both ends, detached from its
original site and translocated to another chromosome, or it
may be reciprocal when two different chromosomes inter-
change parts of their genetic material. Translocation can result
in functional deﬁciency and development of genetic disease if
the translocated chromosome segments are inserted within
intact gene sequences on the recipient chromosome leading
to its disruption. Conversely, translocation might lead to over
expression of the genes at the end of the translocated segment
if they get inserted next to an over expressive promoter of a
recipient gene. Translocations leading to over activation of
oncogenes or causing disruption of critical regulatory genes,
or genes responsible for maintaining genomic stability and
integrity, are known to underlie the development of many
malignant tumors secondary to these peculiar pathogenetic
mechanisms. Examples of such cancers include Burkitt lym-
phoma t(8;14), follicular carcinoma of the thyroid gland
t(2;3), Ewing sarcoma t(11;22), chronic myelogenous leukemia
t(9;22), follicular lymphoma t(14;18) and many others.
Robertsonian translocation is a speciﬁc type of transloca-
tion involving translocation of a small (21–22) or large
(13–15) acrocentric chromosome to another, large or small
acrocentric chromosome. This defect involves fusion of the
long arms of the two acrocentric chromosomes at their
centromeres and loss of both short arms of the two chromo-
somes. Balanced carriers of this defect are phenotypically
normal because they do not suffer relevant genetic deletions,
since the short arms of acrocentric chromosomes do not code
for essential or unique gene products.
Robertsonian translocations have an incidence of about
one in a thousand newborns with its most frequent forms being
between chromosomes 13 and 14, 14 and 21, and 14 and 15.
Most people with Robertsonian translocations have only 45
chromosomes in each of their cells. Their children, however,
might inherit the fusion chromosome and become phenotypi-
cally normal balanced carriers like their carrier parent or they
may inherit a missing or an extra long arm of an acrocentric
chromosome. In unbalanced forms, Robertsonian transloca-
tions cause chromosomal deletions or addition and result in
chromosome trisomy syndromes including trisomy 13 (Patau
syndrome) and trisomy 21 (Down syndrome). Rarely, if both
parents are heterozygous for the same translocation, they have
the possibility of giving birth to homozygous viable offspring
with 44 chromosomes in each of their somatic cells.
(c) Inversion
Inversion denotes breakage of a chromosome segment at
both ends and its reinsertion at its original site in reversed
up-down position. Inversions are classiﬁed into two main types
depending on whether they include the centromere, pericentric
Figure 8 Isochromosome formation.
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the centromere, paracentric inversions. Since inversions do not
result in loss or gain of extra genetic material, inversions do
not cause marked functional deﬁciency. However, if the break
points of the inversion disrupt the sequence of an important
gene, disease state might ensue. Inversions result in disturbed
crossing over during meiosis and production of defective
gametes with low recombination frequency. Depending on
the extent of chromosome segments affected by the inversion,
these defects might be incompatible with normal development
and lead to early spontaneous abortions.
(d) Ring chromosome formation
Ring chromosomes are incomplete chromosome segments
resulting from terminal deletion of variable parts of both chro-
mosome arms with subsequent joining of both arms to form
ring structures. The net loss of genetic material from the
chromosome depends on the extent of deletion of both arms.
Ring chromosome formation can also occur with terminal or
total deletion of one chromosome arm only, and in rare cases
it occurs when telomeres at the ends of a chromosome fuse
without any loss of genetic material from the chromosome.
Pathological consequences of ring chromosomes are caused
by deletion of genes in the telomeric regions of affected
chromosomes.
(e) Duplication
Chromosome duplication occurs when part of a chromo-
some is copied abnormally, resulting in extra genetic material
from the duplicated segment. Duplications arise from aberrant
recombination or unequal crossing-over that occurs between
misaligned homologous chromosomes during meiosis with
consequent reciprocal deletion of the homologous chromo-
somes. Chromosome duplications offer the etiological basis
of gene duplication and gene ampliﬁcation. They also offer
an explanation for the presence of multiple repetitive
sequences along the DNA, since placement of the duplicated
regions adjacent to the original sequence results in formation
of tandem repeats along the DNA. Gene ampliﬁcation due
to duplication is a common phenomenon for many oncogenes
because duplication and ampliﬁcation of oncogenes results in
their over expression with over production of oncoproteins
that confer the malignant phenotype on transformed cells.
Examples of human cancers due to oncogene duplication
and ampliﬁcation include esophageal cancer, gastric cancer,
cervical cancer, colorectal cancer, breast cancer and
neuroblastoma.The ﬁnding that speciﬁc genomic regulatory elements, e.g.
zinc ﬁnger nuclease enzyme, can induce speciﬁc chromosomal
rearrangements, like duplications and inversions, suggest an
evolutionary role for these chromosomal abnormalities. This
event might be considered as a mechanism of genomic evolu-
tion through formation of novel genes that can amplify the
function of parent genes or, alternatively, can undergo one
or successive mutational events converting them to new genes
with new functions. However, the beneﬁcial role of this pre-
sumed evolutionary pathway as identiﬁed in some organisms,
e.g. the mutational conversion of a duplicated digestive gene
in ice ﬁsh into an antifreeze gene [7] is still a matter of debate
waiting for clariﬁcation in human race since most of these
chromosomal rearrangements have pathological effects on
affected subjects. This might be attributed to their being an
expression of genomic instability, rather than of genomic evo-
lution, of the human genome.
(f) Isochromosomes
Normally, duplicated chromosome pairs separate from
each other and get equally distributed to daughter cells by
the attachment of the spindle ﬁbrils to speciﬁc receptor pro-
teins on their common centromere with consequent disjunction
along their longitudinal axis (Fig. 8). Abnormal attachment of
the spindle ﬁbrils or instability of the centromeric region might
result in abnormal separation of the chromosome pair along
its transverse axis so that two chromosomes result: one consist-
ing of the long arms of the pair and the other consisting of the
short arms only, i.e. mirror-image chromosomes. This results
in complete deletion and functional monosomy of the short
arm or the long arm of each resulting isochromosome,
respectively. Isochromosomes have equal arms with identical
banding pattern of both arms. They are seen in some female
patients with Turner syndrome and in many types of myeloid
and lymphoblastic leukemias. They may rarely involve
autosomes, e.g. isochromosome 18q syndrome.
(g) Mosaicism
Chromosomal mosaicism describes the presence of two or
more cell populations with different chromosome comple-
ments in one individual. For instance, mosaic Down syndrome
(46,XY/47,XY,+21), mosaic Turner syndrome (46,XX/45,X)
and mosaic Klinefelter syndrome (46,XY/47,XXY).
Normally, due to Lyonization or X chromosome inactivation,
all female cells are functionally mosaic as regards the X chro-
mosome, i.e. cells with the maternal X inactivated depend on
the paternal X chromosome genes for mediating X
Figure 9 Numerical chromosomal abnormalities.
12 M.S.Z. Salemchromosome-dependent genetic functions, and vice versa.
Pathological mosaicism, on the other hand, occurs when a
mutational event selectively affects one cell and gets transmit-
ted to all descendent daughter cells. It can affect gonadal cells
during meiosis resulting in some gametes carrying the muta-
tion with the rest of the germ cells being free from mutation,
gonadal mosaicism, as well as somatic cells at any stage along
the pathway of cell division after the ﬁrst post-zygotic division.
Accumulating evidence suggests that chromosomal mosai-
cism, probably, represents a signiﬁcant genetic phenomenon
with widespread effects on many aspects of human biology
and health since a signiﬁcant proportion of human pathogenic
conditions is associated with chromosomal mosaicism. Though
mosaicism is a clear demonstration of genetic diversity, its true
signiﬁcance remains, as yet, unknown in view of the contradic-
tory genetic effects attributed to and associated with its
occurrence. For instance, mosaicism is quite a frequent ﬁnding
among human fetuses and is observed in nearly 25% of
spontaneous abortions. It also plays a role in the generation
of meiotic aneuploidy known to be the leading genetic cause
of human prenatal death, congenital malformations, prenatal
mortality and postnatal morbidity, many neuropsychiatric dis-
orders, chromosomal syndromes, learning disabilities, cancer
and immune diseases. Contrariwise, there is strong and
substantial evidence suggesting that increased incidence of
mosaic aneuploidy in the developing human brain is an
integral component of normal prenatal development of the
human central nervous system.
(h) Chromosome gaps and breaks
These distinctive types of chromosomal abnormalities
reﬂect effects and consequences of mutations leading to inter-
ruption of the integrity of the chromosome DNA. They, prob-
ably, predispose to development of many other types of
structural aberrations of the chromosomes [8].
(2) Numerical chromosomal aberrations
Numerical chromosomal abnormalities refer to chromoso-
mal abnormalities caused by the presence of abnormal number
of chromosomes within the cell. These gross mutational events
can involve autosomes, e.g. trisomy 21 in Down syndrome and
hypodiploidy and hyperdiploidy in cancer cells, or the sex
chromosomes like monosomy X (45,X) in Turner syndrome
and XXY abnormality in Klinefelter syndrome (47,XXY)
(Fig. 9).(a) Trisomy, or the presence of three copies of a chromo-
some instead of two, results from non-disjunction, or non-
separation, of duplicated chromosomes after replication.
Normally, during cell division, replication of DNA occurs
and chromosomes duplicate themselves so that each daughter
cell receives the same number of chromosomes like the parent
cell, in order to keep genetic identity of the species. If a dupli-
cated chromosome pair fails to separate from each other and
both chromosomes are distributed to one daughter cell only,
then trisomy of this cell results with concomitant monosomy
of the other daughter cell. Partial trisomy refers to duplication
of certain parts of a chromosome, e.g. the long arm or the
short arm only. It has similar etiological bases like complete
trisomy including non-disjunction, spindle derangements and
centromeric breaks due to genomic instability.
(b) Monosomy means the presence of one single copy of the
chromosome. Autosomal monosomy is incompatible with nor-
mal development and cells with this type of abnormalities die
because of lack of the vital functions of hundreds or thousands
of genes on the missing chromosome. Monosomy of the X
chromosome is the only monosomy compatible with life in
view of the peculiar nature of the genetics of the X chromosome.
Partial monosomy, due to deletion of a part of a chromosome,
is a common cytogenetic abnormality seen in many genetic
syndromes. The spectrum of pathological ﬁndings in each
syndrome depends on the extent of functional impairment
caused by lack of functions of genes lost due to the deletion.
(C) Hypodiploidy refers to chromosome complement less
than the normal diploid (46) chromosome number of somatic
cells. Cells of Turner syndrome with 45 chromosomes repre-
sent the only viable hypodiploid events. Hypodiploidy is a
common cytogenetic abnormality in many malignant cells. In
some cases it might be so extensive that some malignant cells
have chromosome number reaching near haploidy, or 23 chro-
mosomes. Hypodiploidy is an important prognostic marker
for the karyotypic evolution of cancer cells since the smaller
the number of chromosomes a cell can live with, the more vir-
ulent malignant phenotype these cells can have. Milder states
of hypodiploidy, low hypodiploidy with (33–38) chromosomes
and high hypodiploidy with (42–45) are also common cytoge-
netic ﬁndings in malignant cells.
(d) Hyperdiploidy, or chromosome numbers more than 46
chromosomes, underlies the pathogenesis of some genetic
Pathogenetics 13disorders, e.g. trisomy 13–18–21, XXY, XYY and multiple X
syndromes with three or more X chromosomes in cells of
affected female patients. Marked pathological hyperdiploidy
with chromosome number reaching up to seventy (70) or a lit-
tle bit more chromosomes, however, is quite common in many
malignancies like acute lymphoblastic leukemia and acute
myeloid leukemia [9].
7.6.4.2. Pathogenetic mechanisms of chromosomal aberrations.
The pathogenetic mechanisms involved in the pathogenesis
of chromosomal aberrations are, still, mysterious and hardly
understandable. They cannot be interpreted on molecular basis
even for chromosome gaps and breaks in view of the complex
structural assembly of the chromosome and its intimate integ-
rity with the chromatin material. Gross regulatory defects of
mechanisms controlling cell division, including the formation
of the spindle and the timing of its action in synchronization
with other biochemical and signal transduction effectors are
hold responsible for predisposing to non-disjunction and the
development of chromosomal trisomies and chromosomal
monosomies as well. Similar defective regulatory mechanisms
might underlie the development of polyploidy conditions like
triploidy and tetraploidy.
However, the regular and persistent occurrence at nearly
constant incidence rates of well recognized and well deﬁned
genetic defects, including chromosomal aberrations, irrespec-
tive of ethnic, racial or environmental factors, indicates that
these types of genetic changes or mutations might have, still
unknown, deep rooted signiﬁcance background in our genome.
Disclosure of master genes and related genetic factors responsi-
ble for regulating both the stability and behavior of the genome
as a whole will, surely, throw more light on factors underlying
pathogenesis and development of chromosomal abnormalities.
7.6.5. Genomic mutations
Genomic mutations refer to mutations involving the whole
genome (either the 23 chromosomes haploid genome or the
46 chromosomes diploid genome). They comprise numerical
genomic mutations involving the whole chromosome set of
the genome like triploidy (69 chromosomes genome) and
tetraploidy (92 chromosomes genome). They, also, include
functional genomic mutations leading to disturbed and/or
defective expression of the whole genome functions. Genomic
functional mutations reveal their consequences in many pheno-
types. In humans, the development of vesicular or hydatidiform
malls and the formation of dermoid cysts, instead of normal
development of the zygote, represent obvious examples of
genomic functional mutations. Normally, during the ﬁrst ﬁve
days following fertilization and zygote formation, all cellular
processes including cell growth, differentiation and division
are controlled and mediated exclusively by the maternal
genome of the ovum. The sperm genome begins its participa-
tion in these processes after these critical ﬁve days post-
fertilization period. Improper temporal programing of these
genomic balances and interactions, e.g. due to genomic
imprinting mutations, leads to disturbed genomic regulation
of development and differentiation of the developing zygote,
with drastic consequences leading to actual cessation and
disturbed progress of normal development and differentiation.
If the maternal genome fails to start functioning properly after
fertilization or fails to maintain its genetic regulation of devel-
opment over the critical immediate post-fertilization period, orif the paternal genome is prematurely induced to start its roles
in genetic regulation of development and differentiation as a
result of these genomic imprinting mutations, normal embryo-
genesis and/or fetal growth is brought to a stand-still [5].
Genomic functional mutations might, also, be caused by
other pathogenetic mechanisms, one of these abnormal mech-
anisms entails exclusive predominance of one parental genome
in zygote formation and development. The diploid genome of
the zygote may be formed from two maternal haploid genomes
(46, XX) without any sperm genome, or from two paternal
haploid sperm genomes (46,YY) without participation of any
maternal genome. These abnormalities in chromosomal consti-
tution of the zygote can be caused by many pathogenetic muta-
tional events. Endoreduplication of one parental genome of
the zygote with suppression, involution and disappearance of
the other genome, or fertilization of the ovum by two sperm
genomes with consequent disappearance of the ovum genome
from the developing zygote can lead to pathogenesis of these
genomic chromosomal abnormalities. A well-known wide
spectrum of pathological embryonic and fetal malformations
and abnormal conception products results from these genomic
functional mutations (Fig. 10). [6].
Normal development of human embryos is an extremely
complex process mediated under strict control of thousands
of regulatory genomic pathways. Fertilization results in bring-
ing up two different genomes that must work together in pre-
cise concert to attain the ﬁnal aim of the whole process, that is
formation of a normal complete offspring. Though the imme-
diate post-fertilization period is the most genetically active
among all other periods of life of the organism, selective acti-
vation and silencing of the large number of genes constituting
the genome of the zygote is a remarkable feature of this early
stage. Some maternal genes are activated and others are
silenced. The same process applies to parental genes as well.
This phenomenon of selective activation or silencing of genes
based on their parental origin is referred to as imprinting.
Imprinting might involve a single gene, multiple genes or most
genes on a chromosome as in Lyonization of the X chromo-
some, where it is known as gene or genetic imprinting, or it
might involve a whole set of chromosomes of a certain parent,
a condition referred to as genomic imprinting.
Imprinting seems to be a global biological feature of all liv-
ing systems. In spite of accumulating observations, it remains
to be one of the most puzzling phenomena in biology because
of lack of sufﬁcient information regarding the underlying
mechanisms that mediate its effects and also due to the many
species-speciﬁc and inter-species unrelated aspects and mecha-
nisms of imprinting. For instance, regulation of expression of
speciﬁc genes by imprinting is unique to therian mammals, i.e.
placental mammals and marsupials, and ﬂowering plants. The
majority of imprinted genes in mammals have fundamental
roles in embryogenesis and development of the placenta.
Other imprinted mammalian genes are involved in post-natal
developmental processes. Within a different biological context,
for example in insects, imprinting plays a crucial role in sex
determination where genomic imprinting of the whole paternal
genome with consequent functional haploidy is a prerequisite
for normal development into males.
Though many hypotheses have been proposed to explain
the biological aims and the evolutionary origins of imprinting,
e.g. natural selection hypothesis and parental conﬂict hypoth-
esis, imprinting in essence represents a programed regulatory
Figure 10 pathological consequences of genomic structural and functional mutations.
14 M.S.Z. Salemmechanism of the genome to harmonize functions and interac-
tions of the large number of genes that constitute it, so that
integrity and stability of the genome, hence genomic identity,
is maintained, preserved and conserved in spite of the contin-
uously ever changing proteome phenotype and proteome
dynamics of living systems. If genes constituting a speciﬁc gen-
ome are imprinted, either expressed or silenced, without strict
regulatory mechanism(s) controlling temporal aspects of their
functions, widespread random and conﬂicting qualitative and
quantitative changes of the proteome synthesized by that gen-
ome will disturb the stability and integrity of the genome,
through many different mechanisms, leading ultimately to
decadence and loss of the genomic identity that characterizes
living organisms [10].
7.7. Base, sugar, phosphate mutation
Mutations, in general, refer to changes of the bases of the
nucleic acids (A,G,C,T,U) and represent the commonest types
of mutations of the genetic material. However, several kinds of
mutations can affect the sugar and the phosphate group, and
can have deleterious effects on the genetic material. Several
kinds of mutation can affect the sugar portion of the nucleo-
tide. For instance, some physical and chemical mutagens can
add oxygen to the deoxyribose of DNA or remove oxygen
from the ribose of RNA, or a whole deoxyribonucleotide
might be substituted by a ribonucleotide. Such mutations of
DNA, containing a ribonucleotide instead of a deoxyribonu-
cleotide are usually silent, but under abnormal conditions they
might be attacked by ribonucleases leading to DNA breaks.
Another type of mutation of the sugar portion of the nucleo-
tide involves methylation of ribose of a coding nucleotide in
mRNA and can lead to silencing or, even, to total suppression
of translation.
Mutations that affect the phosphorus atom of the nucleo-
tide can cause widespread detrimental effects on the integrity
of the DNA strand. Irradiation turns ordinary phosphorus
to radioactive phosphorus which, upon release of an electron,
changes to non-radioactive sulfur and suffers a recoil in diam-
eter leading to loss of its connection to the adjacent sugar. This
results in multiple recoil breaks in the sugar-phosphatebackbone of the DNA with ultimate breakage mutations of
the nucleic acid [1].
7.8. Persistent and reversible mutation
Mutations are frequent structural genetic alterations in view of
the dynamic nature of the genome. It almost always accompa-
nies replication of DNA and transcription of RNA. However,
most of these mutations are corrected and repaired by the
genomic repair mechanisms. Mutations in one cell that escape
repair are liable to be transferred to daughter cells upon
division and a whole progeny of mutated cells makes its
appearance. Persistence of the mutation and its transfer to
progeny cells results in ﬁxation of the mutation, the change
becomes persistent and appears in all daughter cells. The
outcome of this scenario depends on the type of the cell and
the pathogenetic effects of the resulting damage. Acquired
persistent somatic mutations have the same effects as classic
somatic mutations, they can cause cell death, dysfunction,
apoptosis or malignant transformation. Acquired persistent
germinal mutations might be transferred to offspring, become
heritable and result in inherited genetic disease.
Since mutations are un-programed genetic events, the
term reversible mutations is actually a misnaming since these
mutations represent programed structural genetic alterations
aiming at conducting speciﬁc purposes, e.g. regulation of
gene function. For instance, methylation of bases to silence
gene transcription, acetylation of regulatory DNA associated
histones to enhance transcription and methylation of the
adenine base in some types of mRNA/siRNA species to reg-
ulate energy balance or ATP homeostasis of the cell, are
examples of such reversible changes of the genetic material.
These alterations are sometimes considered as various mech-
anisms of epigenetic alterations, i.e. temporary imposed
structural changes that do not alter the basic nucleotide
sequence of DNA. For simpliﬁcation and to obviate confu-
sion, at least within the scope of human genetics, it might
be more plausible to omit both terms, epigenetics and rever-
sible mutations, and refer to structural genetic alterations
either as mutations or as temporary structural genomic
alterations.
Pathogenetics 158. Pathogenetic mechanisms of genetic diseases
The genetic material controls life activities of the cell through
regulating synthesis of proteins which directly mediate these
activities. Regulatory genes, in addition, control the transcrip-
tion of many classes of small RNAs that have fundamental
roles in direct and feed-back regulation of most aspects of
the genetic material.
Mutations cause structural alterations of the genetic mate-
rial. Depending on the site, nature, magnitude and effects of
the mutational event as well as on the functions and impor-
tance of the mutated genes, pathogenetic mechanisms that
result in deﬁcient synthesis of gene products, synthesis of
defective gene products or disturbed regulation of cellular
activities will lead to development of genetic disorders,
secondary to the ensuing pathophysiological alterations of
cellular functions [9].
Maintaining stability, integrity and species-speciﬁc identity
of the genome represents a prerequisite, not only for executing
cell functions properly, but more fundamentally for beginning,
continuation and conservation of life. It is the preservation of
the collaborative and integrated intimate relationship of these
three aspects of the genome that represent the real kernel and
true essence of existence of all forms of life. Many pathogenetic
mechanisms that drastically affect genome stability and gen-
ome integrity have been deﬁned. These particular groups of
mutations constitute important detrimental events that act
via different pathways, e.g. defective genetic repair mecha-
nisms or premature induction of apoptosis, leading ultimately
to loss of genome stability and integrity and induction of cell
death. On molecular or cellular level, these mutations might
be considered as life-ending mutations. These mutations might
also act in a different way through total loss of reproductive
ﬁtness and disappearance of individual genomes from the gene
pool of certain species.
The spectrum of pathogenetic mechanisms and the resulting
pathophysiological disturbances that underlie the development
of genetic disorders is quite wide in view of the complexity of
the structural organization of the genome and the strict func-
tional specialization that characterizes each of its components.
Additionally, the obscure nature and unclear functions of
many components of the genetic material, undoubtedly, con-
ceal many, still unknown, pathogenetic mechanisms and hin-
der proper understanding of their exact pathways. It is
hoped that ﬁnal completion of the human genome project
might disclose the exact and complete structural organization
of the human genome [11]. However, a parallel human genome
function project aiming at deﬁning the complete functional
spectrum of the genome seems to be an indispensable and
imperative task in order to ﬁnalize our knowledge of our
genetic material.
Currently deﬁned pathogenetic mechanisms and patho-
physiological alterations implicated in the pathogenesis of
genetic disorders include the following:
(1) Loss/damage/duplication/inactivation of nuclear genes
(2) Mutation of mitochondrial genes (mitDNA)
(3) Deﬁcient/defective DNA replication/repair
(4) Triplet repeat expansion disorders
(5) Loss/acquisition/damage of chromosomes
(6) Deﬁcient transcription of mRNA(7) Transcription of defective mRNA
(8) Deﬁcient/defective post-transcription mRNA repair
(9) Deﬁcient/defective post-transcription modiﬁcations of
mRNA
(10) Deﬁcient translation of proteins
(11) Translation of defective proteins
(12) Deﬁcient/defective post-translation modiﬁcation of
proteins
(13) Deﬁcient/defective post-translation repair of misfolded
proteins
(14) Deﬁcient/defective post-translation targeting and traf-
ﬁcking of proteins
(15) Deﬁcient/defective regulation of cell growth
(16) Deﬁcient/defective regulation of cell division
(17) Deﬁcient/defective regulation of cell differentiation
(18) Deﬁcient/defective regulation of cell migration
(19) Deﬁcient/defective regulation of intercellular contact
and cell movement
(20) Deﬁcient/defective apoptosis/selection repair
(21) Deﬁcient/defective regulation of cell architecture and
cytoskeleton: e.g. ciliary dyskinesia disorders
(bronchiectasis, dextrocardia and situs-inversus,
hydronephrosis, hydrocephaly, male infertility and
repeated abortions), hereditary spherocytosis, Wiskott–
Aldrich syndrome and neural tube defects.
(22) Imprinting disorders: genomic imprinting disorders, e.g.
ovarian teratomas and hydatidiform moles, and genic
imprinting diseases, e.g. Prader–Willi syndrome,
Angelman syndrome, Silver–Russell syndrome,
Beckwith–Wiedemann Syndrome.
(23) Deﬁcient/defective regulation of cellular functions:
(a) Deﬁcient/defective transport across cell membrane or
membranes of cell organelles (transport defects)
(b) Deﬁcient/defective transport across cell pores, nuclear
pores or pores of cell organelles (chanellopathies)
(c) Deﬁcient/defective secretion of gene products (pro-
tein/enzyme deﬁciency disorders)
(d) Deﬁcient/defective excretion of metabolic waste prod-
ucts (storage disorders)
(e) Deﬁcient/defective regulation of intra and inter net-
work reactions and interactions: signal transduction
disorders: e.g. neurodegeneration, diabetes mellitus,
schizophrenia and Noonan syndrome.
(f) Deﬁcient/defective positioning of structural proteins
(cell cytoskeleton disorders)
(g) Deﬁcient/defective regulation of intracellular
trafﬁcking.
(h) Deﬁcient/defective production of cellular energy:
oxidative-phosphorylation disorders.
(i) Ubiquitination/proteasome degradation defects: e.g.
Friedreich ataxia, Huntington disease, Parkinson dis-
ease, Alzheimer disease, Angelman syndrome, motor
neuron disease and immunodeﬁciency.
(j) Apoptosis defects: e.g. congenital malformations,
autoimmune disorders, cancer and neurodegeneration.9. Anti-mutation mechanisms of the human genome and human
proteome
The human genome develops, persists and works in a hostile
environment full of existing, and continuously generated,
16 M.S.Z. Salemmutagens. Mutational events induced by external factors,
which include physical, chemical and biological mutagens,
have widespread detrimental effects on the stability and integ-
rity of the genome as well as on the stability and integrity of
the proteome. Additionally, further and considerable damage
of the structural organization and functional capabilities of
both the genome and the proteome regularly occurs on contin-
uous and progressive basis due to the continuously generated
burden of internal mutagens that result from the diverse meta-
bolic activities of the exceedingly large number of metabolic
networks of the cell. Unless a powerful and effective protective
and repair system actively participates in protecting the gen-
ome and proteome of the cell against the deleterious effects
of mutations, and in efﬁcient repair of resulting damage, main-
taining the stability and integrity of both of these bio-systems
that constitute the framework of life activities within the cell
would have been impossible.
The human genome is endowed with a spectacular multi-
faceted strong anti-mutation system responsible for maintain-
ing stability and integrity of the genome and preserving its
identity. It acts by protecting the genome from the detrimental
effects of mutation and by repairing mutation-induced dam-
age. Obviously, the balance between the pathological effects
of mutation and the ability of the anti-mutation system to
counteract and to reduce the consequences of these effects rep-
resents the main factor that determines the likelihood of hav-
ing a mutation-induced genetic disease. The human anti-
mutation system comprises both innate mechanisms common
to, and shared by, all individuals, e.g. degeneracy of the genetic
code, and acquired aspects determined by the inherited genetic
background of each human being, e.g. DNA repair system.
The human transcriptome, being subjected to the same
mutational events that can affect, alter and damage the
DNA, seems to have efﬁcient anti-mutation mechanisms to
guard against occurrence of errors during RNA transcription
and to correct and repair some post-transcription defects of
mRNA that can cause errors during protein translation. A
separate RNA-proofreading system seems to exist and it
probably acts during transcription by relying on the sequence
complementarity information or database stored within
the complementary silent or non-transcribing strand of
DNA. Depending on the sequence of the active strand to
ensure accurate transcription might result in improper
transcription if mismatch errors occur due to, e.g. polymerase
dysfunction. This assumption might, partly, explain the still
un-understandable behavior of gene function which involves,
seemingly needless, indirect and energy consuming mecha-
nisms by transcribing a complementary mRNA molecule,
rather than an identical mRNA, that has to be decoded again
by rRNA and tRNA in the ribosome during translation.
10. Anti-mutation mechanisms of the human genome
10.1. Structural organization of the human genome
The peculiar structural organization of the human genome rep-
resents the ﬁrst innate anti-mutation mechanism in view of the
presence of large interspersed portions of non-functional intra-
genic, introns, and inter-genic DNA sequences and segments
that can be mutated without having appreciable deleterious
functional effects. In addition to functional sequences neededfor synthesis of protein and of regulatory small RNA species,
the human genome has a considerable amount of repetitive
DNA sequences, including both noncoding repetitive DNA
sequences and multiple copy genes and gene fragments, a large
number (19,000–21,000) of pseudogenes, a considerable sizable
portion (about 1/6th of the total genome size) as pyknons, a
quite large portion (nearly 40% of the total genome size) as
transposons and large numbers of multiple copies of functional
genes that share the same regulatory function and whose sup-
pression or damage by mutation can be tolerated by other genes
having the same function. These peculiar structural features of
the human genome allows for occurrence of mutational events
in many segments of the genome without having appreciable
functional defects. Even if some of these genes or DNA
sequences have important roles in genome function, their pres-
ence in multiple repetitive copies can greatly reduce, or even
nullify, the consequences of mutational damage resulting from
affecting many copies.
The presence of multiple copies, hundreds to thousands, of
mitochondrial genes within the mitochondria of each cell is
crucial in obviating devastating mutation-induced damage to
these vital organelles in view of their role in production of
ATP. This feature of mitochondrial genome allows for consid-
erable burden of mutations to affect it before appreciable
pathological consequences result. It is estimated that muta-
tions affecting nearly 80% of certain mitochondrial genes
might occur before pathological manifestations of mitochon-
drial genetic diseases make their appearance due to this multi-
ple copy feature of mtDNA [1].
10.2. Structural features of DNA
DNA exists as a double stranded structure composed of two
tightly bound strands, each strand consisting of a straight
sugar-phosphate backbone with opposing nitrogenous bases
linked by glycosidic linkage to the sugar of one strand and
by hydrogen bonds with a complementary base on the other
strand. This speciﬁc structural organization of DNA serves
many purposes. It stabilizes the dynamics of the molecule, per-
mits replication and duplication of the genetic material, pro-
tects the interiorly located bases and, most important, stores
a template or copy of the genetic information ready for use
in case of damage of the other strand. If small or gross muta-
tional events affect important functional portions of the
genetic material, repair mechanisms can restore the exact
sequence of the damaged or lost or deleted parts through
restoration mechanisms based on the complementary informa-
tion of the other strand. Mutations leading to damage of cor-
responding segments of both strands represent a catastrophic
event to the genome due to the absence of the sequence data-
base needed for the repair mechanism to deﬁne the exact base
sequence of the newly synthesized segment in place of the
deleted or grossly damaged segment.
10.3. Degeneracy of the genetic code
Degeneracy of the genetic code represents the third innate anti-
mutation mechanism of the human genome. This feature per-
mits the occurrence of same-sense point mutations in func-
tional codons without changing the amino acid deﬁned by
the mutated codon. Since some amino acids, as a part of a
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maintaining correct protein structure and in mediating proper
protein function, point mutations leading to replacement of
these essential amino acids by other amino acids, missense
mutations, that can’t perform the functions of the original
amino acids might result in detrimental effects on the struc-
tural integrity and stability of the protein followed by deleteri-
ous consequences on physiological function of the protein.
Hence, degeneracy of the genetic code allows for occurrence
of many point mutations, the commonest type of mutational
events and the commonest cause of genetic disorders, without
changing the ﬁnal structure of the synthesized protein, thus
protecting against, and obviating, the pathological effects of
these mutations.
10.4. Nuclear localization of DNA
The localization of DNA deep inside the cell nucleus repre-
sents a fourth innate anti-mutation mechanism of the human
genome because it acts as a physical barrier against many
mutagens that have to overcome many obstacles of cellular
defense mechanisms in order to affect the nuclear genome.
These defenses include the extra-cellular environment, the cell
membrane, the cytoplasmic mass, the cytoplasmic enzymes
and phagocytic cellular organelles and the cytoplasmic and
nuclear antioxidant enzyme systems.
10.5. DNA-associated proteins
The DNA-associated or DNA-binding proteins, in addition
to their essential roles in regulating transcriptional processes
of most genes, also play fundamental roles in protecting the
DNA from the damaging effects of many mutagens, in par-
ticular the free radicals that are generated during metabolic
activities of the cell. They act as physical barriers and bio-
chemical buffers, modiﬁers or deactivating biomolecules of
many chemical mutagens or damaging factors that might
harm the DNA. They mediate this protective role by many
mechanisms including modulation of charge transport of
oxidative agents within the DNA, limitation of DNA helix
distortion and regulation of protein-dependent alterations in
DNA base stacking [1].
10.6. Replication proofreading system
Preservation of genomic identity of the organism depends
exclusively on accurate replication and synthesis of two identi-
cal copies of the genome during cell division, followed by
transfer, or inheritance, of each copy to each daughter cell.
In this manner, all cells descendent from a parent cell have
nuclear genomes identical to those of the mother cell. The
majority of spontaneous point mutations of the nuclear gen-
ome are prone to occur during cell division, mostly during
DNA synthesis or the replication phase of the process. The
replication proofreading system acts in a prophylactic way to
ensure accurate insertion or addition of the proper nucleotide
to the newly synthesized strand of replicating DNA. This pro-
phylactic function is fundamental to reduce the rate of inevita-
ble replication mistakes to minimum levels that could be dealt
with efﬁciently with the DNA repair mechanisms. In spite of
the impressively fast and accurate ability of the enzymesresponsible for DNA synthesis, the DNA polymerases, most
of them have additional proofreading ability to ensure accu-
rate error-free DNA replication and, hence, maintaining and
preserving the stability, integrity and identity of the genome
during cell division, as well as during transfer of the genetic
material from parents to offspring.
10.7. Genetic repair systems
Genetic repair systems responsible for correcting and repairing
many different types of point and small mutations that affect
the genetic material, whether induced by exogenous mutagens
or occurring secondary to endogenous spontaneous alter-
ations, comprise both nuclear DNA repair system and mito-
chondrial DNA repair system. Genetic function and genetic
repair represent two sides of one coin. Without the persevering
continuous, active and effective surveillance exerted by the
genetic repair systems to detect and repair the continuously
and persistently occurring mutations, maintaining stability
and integrity of the genome would be an impossible task.
These repair systems consist of large numbers of enzymes, pro-
teins and related factors that function in complementary and
collaborative mechanisms along speciﬁc pathways, with each
of them having a predeﬁned role in the repair process. For
instance, if mutation causes damage of a genetic segment con-
sisting of sequence of nucleotides, an endonuclease enzyme
cuts both sides of the damaged segment, followed by addition
of proper nucleotides instead of the damaged or deleted ones
by a polymerase enzyme, then a ligase enzyme joins the ends
of the newly added segment of nucleotides to the original
neighboring nucleotides by forming phosphor-di-ester bonds
between the phosphate and the sugar of adjacent nucleotides,
thus, regaining the sugar-phosphate backbone of the DNA [2].
10.7.1. Nuclear DNA repair
Nuclear DNA repair mechanisms comprise many approaches
to repair mutations of DNA. These approaches include differ-
ent pathways and sub-pathways according to the type, site and
extent of the mutation-induced damage and also according to
the stage of cell cycle affected by the mutation. They include:
base excision repair (BER), nucleotide excision repair
(NER), direct reversal repair, mismatch repair, transcription-
coupled repair (TCR) and recombination repair (Fig. 11).
10.7.1.1. Base excision repair (BER). This repair mechanism is
probably the most frequent DNA repair pathway in the cell. It
is used for single strand point mutations affecting one or few
bases of one DNA strand. It involves recognition of the dam-
aged base of a nucleotide by a glycosylase enzyme and its
removal by detaching it from the deoxyribose sugar via hydrol-
ysis of the N-glycosyl bond. Breakage of the hydrogen bond
between the damaged base and the opposing base on the com-
plementary strand occurs, probably, via ATP-induced changes
of the energy dynamics of the bond. Removal of the damaged
or mutated base results in creation of abasic site or
apurinic/apyrimidinic site (AP) of the DNA which are targeted
by endonuclease and lyase activity to remove the damaged
base(s) followed by addition of new normal base(s) by a speci-
ﬁc polymerase enzyme and, ﬁnally, regaining the phosphodi-
ester bonds and, hence, the phosphate-sugar backbone of the
DNA strand by the action of DNA ligase.
Figure 11 DNA repair mechanisms.
18 M.S.Z. Salem10.7.1.2. Nucleotide excision repair (NER). Nucleotide exci-
sion repair is one of the most important DNA repair systems
and is highly conserved among species, though it is much more
complicated in higher eukaryotes than prokaryotes. The most
prominent feature of this repair system is its broad substrate
speciﬁcity because it can excise DNA lesions such as UV-
induced pyrimidine dimers as well as more bulky adducts of
DNA.
10.7.1.3. Direct reversal repair. This repair mechanism can
directly repair UV-induced pyrimidine dimer formation and
alkylation adducts by DNA photolyase enzymes and alkyl-
transferase proteins, respectively. Direct reversal repair mech-
anisms are not followed by incision of DNA strands or
resynthesis of new DNA since the changed or mutated bases
are directly reverted to their original states either by light-
dependent photoreactivation process, for pyrimidine dimers
repair, or by use of alkyltransferase. Placental mammals do
not have photolyase-dependent repair mechanisms and depend
on nucleotide excision repair to correct and repair UV-induced
pyrimidine dimer formation.
10.7.1.4. Mismatch repair (MMR). The mismatch repair
(MMR) system recognizes and correctsmismatched or unpaired
bases that result from errors of DNA polymerase during DNA
replication. It involves complex reactions and interactions of
many enzymes, proteins and signal discrimination factors, prob-
ably in collaboration with the proofreading system, to recognize
the mutated strand ﬁrst and then to locate the site of the mis-
matched pair. This is followed by removal of the mutated
sequence by an endonuclease, addition of new pair(s) by DNA
polymerase and ﬁnal regain of the DNA double stranded struc-
ture by DNA ligases. Post-replication mismatch repair is
achieved by removal of a relatively long tract of mismatch-
containing oligonucleotides, a process called long-patchMMR.
10.7.1.5. Recombination repair. Recombination repair mecha-
nisms aim primarily at repairing double-strand breaks of
DNA which represent the most devastating mutation-
induced lesions of DNA because they can lead to loss of
genetic information and chromosomal instabilities with conse-
quent pathological alterations including chromosome break-
age syndromes and carcinogenesis. Double-strand breaks canbe caused either endogenously during DNA replication due
to replication errors, e.g. replication fork collapse, or exoge-
nously by, e.g. ionizing radiation. Recombination repair mech-
anisms consist of many various steps: end resection, strand
invasion, DNA repair synthesis, branch migration and
Holliday junction resolution, and include, at least, two differ-
ent repair pathways: homologous recombination repair (HR)
and nonhomologous end-joining repair. HR repair mechanism
is the accurate pathway and makes use of undamaged homol-
ogous DNA as a template for repair. Non-homologous end-
joining repair mechanism directly ligates two double-strand
break ends together, and although it is efﬁcient, it is prone
to loss of genetic information at the ligation sites. However,
there are many anti-recombination mechanisms to suppress
excessive recombination that might lead to loss of genetic
information and genomic instability [1].
10.7.2. RNA repair/editing system
RNA editing refers to molecular modiﬁcations of nucleotides of
RNA through chemical changes in the base makeup of the
molecule. Such changes appear to be present in all three
domains of life, and involve both coding, mRNA, and non-
coding, tRNA and mRNA, types of small or microRNA.
RNA editing occurs in the cell nucleus and the cytosol, as well
as in mitochondria and is mediated by a complex repair system
comprising many species of small RNA (guide RNA) and large
protein complexes known as the editosomes. The pathways of
RNA editing include many diverse processes: nucleoside base
modiﬁcations such as cytidine (C) to uridine (U) and adenosine
(A) to inosine (I) deaminations, as well as non-templated inser-
tions of nucleotide. RNA editing in mRNAs effectively alters
the amino acid sequence of the encoded protein so that it differs
from that predicted by the genomic DNA sequence. Though
mRNA editing is used in many instances to allow for synthesis
by the cell of more than one protein from the samemRNA tran-
script, e.g. synthesis of both apolipoprotein B-100 and
apolipoprotein B-48 from the same mRNA in liver cells, it
can also be used to repair missense or termination mutations
of themolecule which can have deleterious effects on the synthe-
sized protein. Speciﬁc endonucleases and ligases for double
stranded species of RNA have been deﬁned in many prokary-
otes and it might be just a matter of time before deﬁning their
functional counterparts in eukaryotes and human cells.
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The pivotal role played by the mitochondrial genome in gener-
ating ATP, without which life can neither begin nor persist, in
addition to the many other critical metabolic and regulatory
functions of mitochondrial genes, requires the presence of an
efﬁcient system for repairing mtDNA mutations. The need
for mitochondrial genome repair system is further imposed
on the cell in view of the high mutation rate of mitochondrial
genes which lack many of the anti-mutation and protective
mechanisms available to nuclear genes. Similar to the nuclear
genome repair system, mitochondrial repair system includes
many repair pathways: base excision repair, direct reversal
repair, mismatch repair, and recombination repair.
Nucleotide excision repair (NER) pathway, however, seems
not to be working in the mitochondria [12].
10.8. Protein repair systems
Accurate post-translation structural conﬁguration of newly
synthesized polypeptide chains is a fundamental conforma-
tional modiﬁcation for most proteins to become functionally
active biomolecules. The maturation from primary to quater-
nary protein structure involves many changes, e.g. folding
and maintenance of steric and spatial relationships between
the different domains of the protein. Conformational defects
in proteins that might happen during these modiﬁcations can
lead to the formation of misfolded and/or aggregated non-
functional molecules.
Human genome comprises a large number of genes that
code a complex system composed of large numbers of speciﬁc
protein families and subfamilies known as molecular chaper-
ones. These proteins have many important and diverse func-
tions in cellular activities, e.g. assisting non-covalent folding
or unfolding and assembly or disassembly of macromolecular
structures, including proteins. Prevention of misfolding and/or
aggregation of newly synthesized polypeptide chains, which
turn them to nonfunctional biomolecules, is a major and fun-
damental function of molecular chaperones. Other physiolog-
ical functions of chaperones include: transport across
mitochondrial membranes and the endoplasmic reticulum
and assistance in protein degradation.
Molecular chaperones, probably, exert critical roles in
maintaining stability and integrity of the proteome. This state
of protein homeostasis, proteostasis, is a prerequisite for
proper control and regulation of cellular metabolic networks
by proteins and is mandatory for efﬁcient mediation of cellular
activities. Speciﬁc species of molecular chaperones, surveil-
lance chaperones, are responsible for constant surveillance of
the proteome to ensure proper protein homeostasis.
Age-related decline or mutation-induced defects in proteome
stability and integrity results in progressive aggregation and
faulty conformational changes of proteins, both of which are
associated with, and underlie, the development of many
genetic diseases like Alzheimer disease, Parkinson disease,
prion diseases and many others [13].
10.9. Silencing of transposon activity during development
Transposons constitute a considerable portion, nearly 40%, of
the human nuclear genome. Transposon activities might have
contradictory effects on the stability and integrity of thenuclear genome. They might behave in a harmful way and
act as major potential causes of spontaneous mutations of
the nuclear genome. They can make a copy of themselves
and insert the new copy in another site, or they can detach
themselves from their location and get inserted at different
sites of the genome (Fig. 12). In both conditions they result
in insertional mutagenesis with consequent deleterious effects
on genomic stability and genomic integrity. If they get inserted
in a functional segment of the genome they lead to structural
disruption and loss of function of the affected segment with
resultant pathological effects. Alternatively, transposon activ-
ity may lead to creation and construction of new genetic com-
binations that may have speciﬁc functions. Within this context,
they would be considered as one of the genetic biological
mechanisms involved in, and responsible for, evolutionary
diversity of the genome and the proteome. They can also cause
tangible increases in the amount of the genetic material due to
recurrent synthesis and addition of multiple new copies of
transposable elements to the nuclear genome.
Transposons probably have a central regulatory role in the
early development of the embryo. A key feature of this activity
involves a speciﬁc type of transposable element (MuERV-L)
which is uniquely active during the totipotent cell phase of
embryogenesis. A network of regulatory genes that are partic-
ularly active during early development depends on this trans-
posable element to activate their promoter areas in order to
start their transcriptional activities. The early timed enhance-
ment of the regulatory functions of this genetic network seems
essential for proper differentiation of the totipotent cells which
play fundamental roles in development and differentiation. As
development continues, progressive silencing of the genes of
this regulatory network takes place. This delicate balance in
temporal regulation of transposon activity is critical for
embryogenesis and development as well as for proper develop-
ment of germ line cells, particularly those in spermatocytes
during spermatogenesis [14].
Over activity or uncontrolled activity of transposons can,
thus, have detrimental and devastating effects on embryogen-
esis, differentiation and development, and can lead to the
pathogenesis of a wide variety of congenital malformations
and genetic defects. The human genome, however, has a
unique control system composed of a speciﬁc subtype of small
or micro RNA molecules, known as piwiRNA, or piRNA,
composed of RNA-piwi protein complexes. They are thought
to be involved in gene silencing, most speciﬁcally the silencing
of transposons. The majority of piRNAs are antisense to
transposon sequences suggesting that transposons are the main
target of piRNA. In mammals, the marked activity of piRNAs
in silencing of transposons and control of their activities is
most important during the development of the embryo in
order to reduce the rate and risk of transposon-induced muta-
tions during this sensitive period of life [15].
10.10. Antioxidant enzyme systems
The continuous functioning of the exceedingly huge number of
metabolic networks that mediate cellular activities in living cells
results in continuous generation of many different types of use-
ful and harmful metabolic by-products. Oxidant free radicals
constitute one of the most crucial categories of these by-
products in view of their ability to induce widespread damage
Figure 12 Transposons: methods of transposition. (Lauren Solomon, Broad Institute of Harvard and MIT),
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and structural macromolecules like lipids and proteins. This
structural damage, unless counteracted by opposing antioxi-
dant mechanisms, results in progressive degradation of cellular
constituents with consequent resultant pathophysiological
alterations of cellular functions, leading ultimately to disease.
Although low concentrations of reactive oxygen species may
be beneﬁcial, or even necessary, in mediating many cellular pro-
cesses, e.g. defense against invading micro-organisms and intra-
cellular signaling pathways, nevertheless, higher concentrations
of these free radicals play a causative role in the aging process
as well as in the pathogenesis of many human disease
states, including immune deﬁciency, neurodegeneration and
cancer. Oxidative damage of nDNA, mtDNA, RNA and
DNA-binding proteins by free radicals represents an important
category of detrimental genetic mutations induced by
endogenous chemical mutagens inevitably generated during
cellular metabolic activities and other cellular functions.
Living cells have several efﬁcient non-enzymatic and enzy-
matic antioxidant activities that are responsible for eliminating
and/or terminating the chain reactions following generation of
free radicals, as a safeguard against their damaging effects on
cellular components and cellular functions. Enzymatic antiox-
idant systems of the cell comprise large numbers of multiple
types of antioxidant enzymes, notably catalase, superoxide dis-
mutase, thioredoxin reductase, glutathione peroxidase and
various other peroxidases. Efﬁcient production of these antiox-
idant enzymes and proper regulation of their functions is
mandatory to keep and maintain redox homeostasis of the cell
which is a critical prerequisite for normal mediation of cellular
activities [16].
10.11. Apoptosis of heavily, lethally mutated cells
Apoptosis, or programed cell death, is a universal biological
behavior of most living cells necessary, in conjunction with
other life-regulating mechanisms, for maintaining the vital
balance between life and death that governs optimal life condi-
tions of multicellular organisms. Apoptosis plays fundamental
and crucial roles in normal growth and development as well as
in normal differentiation and determination of the proper ﬁnal
architecture of cells, tissues and organs. Faulty timing orincorrect accomplishment of speciﬁc and selective apoptotic
processes during each of these life stages of the cell might
results in devastating consequences on cellular functions that
range from dysfunction to malformation, and may, even, cul-
minate ultimately in premature cell death and pathogenesis of
disease [17].
Apoptosis plays a crucial role in maintaining genomic sta-
bility and integrity, not of individual cells, but of the organism
as a whole. Induction of apoptotic mechanisms in heavily
mutated or lethally mutated cells leads to death of the cell
and prevents transfer of these mutations to its putative
descendant daughter cells. This fundamental prophylactic
anti-mutation role of apoptosis in cellular activities and life
prospects of living organisms has more far-reaching effects on
many important aspects related to the balance between, and
the incidence of, normal and mutant genotypes within
species-speciﬁc gene pools. Additionally, apoptosis can affect
in an appreciable manner genomic identity of living organisms
because mutation-induced evolutionary or decadence pathways
are largely dependent on the outcome of certain apoptotic
mechanisms operating during certain stages of the cell cycle.
10.12. Melatonin
Melatonin is a hormone synthesized by the pineal gland, bone
marrow cells, epithelial cells and lymphocytes. Melatonin
receptors are distributed in most organs, a ﬁnding reﬂecting
its widespread roles in regulating various physiological and
psychological processes. Many in vitro and animal studies
revealed that melatonin has diverse functions including effec-
tive protection of cells against radiation-induced chromosome
breakage and inhibition of tumor development in animals
exposed to experimental chemical carcinogenesis [18].
Melatonin was shown to have protective effect against
oxidative DNA damage by chemical inactivation of
DNA-damaging agent as well as by stimulating DNA repair
mechanisms. These anti-mutagenic and anti-clastogenic effects
of melatonin can be linked with its ability to protect DNA
against oxidative damage. It may exert this antioxidant action
by eliminating harmful reactive oxygen radicals or by stimulat-
ing the repair processes of oxidative stress-induced damage of
DNA [19] [Table 2].
Table 2 Anti-mutation mechanisms of the human genome.
Anti-mutation mechanisms of the human genome
Mechanism Types & pathways & comments
1. Structural organization of the
genome
1. Nuclear genome
2. Mitochondrial genome
2. Structural features of DNA Complementary strand stores genetic information
3. Degeneracy of the genetic
code
Multiple point mutations might occur without aﬀecting synthesized protein
4. Nuclear localization of DNA Physical protection of nuclear genome
5. DNA-associated proteins 1. Physical barriers
2. Biochemical buffers
3. Deactivating biomolecules
4. Modulation of charge transport
5. Limitation of DNA helix distortion
6. Replication proofreading
system
Prophylactic pathway during DNA replication
7. Genetic repair systems A. Nuclear DNA repair
1. Base excision repair
2. Nucleotide excision repair
3. Direct reversal repair
4. Mismatch repair
5. Recombination repair
B. RNA repair/editing system Post-transcription repair/editing of some mRNA defects via guide RNA
(gRNA)/editosome complex
C. Mitochondrial DNA (mtDNA) repair
8. Protein repair systems Correction of post-translation protein misfolding/aggregation by chaperones
9. Silencing of transposons by
piwiRNA
Reduces transposon-induced mutations during development
10. Antioxidant enzyme systems
11. Apoptosis Prophylactic pathway against spread of mutations of heavily or lethally mutated genomes to daughter cells
12. Melatonin Anti-clastogenic, anti-mutagenic, anti-carcinogenic and anti-oxidant compound
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Among known pathogenetic mechanisms implicated in devel-
opment of genetic disorders, the phenomenon of genetic
imprinting represents one of the most puzzling phenomena
in genetics. Genetic imprinting refers to differential functional
expression/repression of chromosomes, parts of chromo-
somes, single genes or sets of genes. The differential expres-
sion/repression of imprinted component(s) depends on
either the parent of origin (parental imprinting), the adjacent
DNA-associated proteins (spatial imprinting) or the timing of
post-fertilization development (temporal imprinting). Though
pathogenetic mechanisms caused and mediated by defective
temporal and spatial imprinting are self-explanatory, those
due to parental imprinting are, still, unexplained.
Imprinting probably represents one, among many, species-
speciﬁc innate genomic mechanisms responsible for the estab-
lishment of the cardinal fundamental aspects of genomic
identity including the formulation of characteristic species-
speciﬁc proﬁles of the transcriptome and the proteome and
the development of sexually distinctive phenotypes. Though
current observations point to the possible roles of
microRNA and chromatin components in mediation and
maintenance of imprinting processes through biochemical
molecules/networks, imprinting might be mediated by other
different unexpected mechanisms apart from the currently
identiﬁed conventional biochemical mechanisms, e.g. the geo-
magnetic imprinting postulation [20].12. Biological consequences of mutation
12.1. Mutation and genetic adaptations to stress
Although the development and appearance of new biological
functions secondary to environmental effectors or endogenous
mutational events reﬂect the concept of adaptation, a funda-
mental and universal biological principle shared by living
organisms and indispensable for any biological systems exist-
ing in a continuously varying and stressful environment, adap-
tation needs not be considered as modiﬁcations secondary to
genomic alterations. As referred to previously, the concept of
evolution is hard to consider unless solid evidence of progres-
sive and appreciable increase in proteome size accompanied by
parallel increase in genome size from simple to more complex
biological systems, e.g. from unicellular to multicellular
organisms, is documented. Actually, this is not the case as
many simple organisms have larger genomes than more
complex organisms. This might be interpreted by more liability
of simple organisms, which have simple cellular architecture
and deﬁcient protective mechanisms, to infection by invading
viruses capable of amalgamating their DNA with host DNA
with consequent increase of size of host genome, compared
to more complex organisms that have protective and anti-
mutation mechanisms against infecting viruses.
Reconsidering the proteome as being a separate and inde-
pendent biological system participating in deﬁning life frame-
work of living cells, not merely a tributary structured system
22 M.S.Z. Salemsynthesized under regulatory control of the genome, might
help in interpreting some perplexing aspects of mutation-
induced evolutionary adaptation. Duplication of the genetic
material, either on gene level or chromosome level, is looked
at as evolutionary solution to stress and evidence of their
occurrence in yeast has been revealed in many studies [21].
Increased genome size in response to stressful conditions, nev-
ertheless, should be induced ﬁrst by deﬁciency in proteome
functions because stressful environmental stimuli exert their
unfavorable impact ﬁrst on the metabolic networks in the
cytoplasm or in other cellular components. They do not affect
the genome in a straightforward way except under certain
extraordinary conditions, e.g. direct damage to genes.
Neither qualitative nor quantitative changes of the proteome
have direct or lasting effects on constitution of the genome
in a manner capable of compelling the genome to respond in
an adaptive way leading to duplication of some of its compo-
nents. Compensatory increase of gene product in response to
stressful conditions can be attained via increasing gene expres-
sion by many known mechanisms, e.g. enhancing transcription
through promoter activation, increasing stabilization of
mRNA and multiple translation rounds of the same transcript,
without need to increase genome size by gene or chromosome
duplication. Modiﬁcations of DNA-associated histones, for
instance, have both enhancing and silencing regulatory effects
on concerned genes but they do not result in, or induce, genetic
duplications or increase in genome size.
12.2. Mutation and evolutionary variation
In spite of the exquisite ability of the protein translation sys-
tem in recognizing and decoding the mRNA transcript and
harmonizing the actions of tens to hundreds of factors
involved in protein synthesis, it can’t recognize changes of
the original genetic code embodied within the codon sequence
of the mRNA transcript. It decodes and recognizes triplets of
bases, or codons, along the transcript without giving attention
to whether they are comparable and complementary to the
original sequences of the gene or not. It seems that the protein
translation system has no prior memory to predict the validity
of the codon sequence of the mRNA transcript in respect to
both the gene sequence and the amino acid sequence of the
protein. Though this defect of the translation system might
be considered as a prerequisite for evolutionary variation of
protein phenotypes necessary for acquisition of new functional
abilities, e.g. formulation and construction of new metabolic
pathways, it is a major cause of pathogenesis of genetic defects
due to the absence of a translation proofreading and repair
system in comparison with the DNA and mRNA repair sys-
tems. Absence of genetic memory necessary for proofreading
of translated proteins is enigmatic and bewildering in view of
the prime and critical signiﬁcance of the translation process,
since the majority of genetic diseases result from synthesis of
defective proteins or deﬁcient synthesis of required proteins.
Though it might be considered as a genomic regulatory mech-
anism allowing for selective pressure to proceed in favor of
evolutionary variation, it results in marked pathological effects
on the organism if newly synthesized proteins are structurally
defective, a ﬁnding that poses the concept of biological
evolution in direct contradiction with our current knowledge
regarding the structural and functional characteristics of boththe genome and proteome. Stressful environmental conditions,
traditionally considered as the main triggers of evolutionary
adaptations, affect the proteome of the cell ﬁrst.
Accordingly, if assumptions regarding genomic adaptations
as evolutionary processes are postulated, they have to reveal
ﬁrst how primary disturbances in structure or function of the
proteome can lead to adaptive changes in structure and func-
tion of the genome. This feature is not to be confused with pro-
tein repair mechanisms conducted by the chaperones family of
proteins which have the ability to correct some aggregation
and misfolding defects of already synthesized proteins, in addi-
tion to many other important cellular functions, but have
nothing to do with decoding and recognition defects during
the actual process of translation and protein synthesis [22].
Though the possibility of formulating novel, meaningful
metabolically active networks composed of, and mediated
by, new functioning proteins synthesized as a result of defec-
tive translation, is extremely difﬁcult to accept or to interpret
by the basic concepts of randomness and/or coincidence, its
occurrence will be temporally limited by the life cycle of the
cell. Unless adaptive genomic changes creating new genes cod-
ing for the new proteins occur, newly formulated networks
can’t be maintained, ﬁxed or inherited. Some sort of interactive
feedback mechanism between the proteome and the genome,
similar to classic stimulus–response pathways, might exist
and represent the missing link mediating this proteome-
genome interaction. However, these assumptions rely, basi-
cally, on the hypothesis of participation of the proteome, as
a separate and independent regulatory structured system, in
conducting life processes in the cell and in inducing adaptive
and sustained changes of the genome. Alternatively, support-
ers of the theoretical hypothesis which postulates that evolu-
tion and divergence could be initiated, mediated and
maintained, primarily, by genomic adaptation in response to
stressful or demanding environmental conditions have to
reveal induced mutagenic beneﬁcial effects capable of causing
increases in genome size. Currently known mutagens, e.g.
irradiation-chemicals-viruses, are damaging agents and result
in detrimental effects and pathogenetic consequences leading,
in most instances, to disease.
12.3. Mutation and natural selection
The concept of mutation-induced natural selection might be
applicable in nature but not in life. The continuing occurrence
and persistence of genetic defects deleteriously affecting bio-
logical ﬁtness, as measured by survival and reproduction,
among humans contradicts assumed roles attributed to natural
selection as a major effector of adaptation and evolution.
Mutations that cause these genetic defects occur spontaneously
at a more or less constant rate among most populations.
Eradication or lessening their harmful burden can be achieved
only by targeted, rather than by natural, selection, e.g. through
pre-implantation diagnosis, prenatal detection and termina-
tion of pregnancy and other similar prophylactic genetic
measures. In the animal kingdom, for instance, there is no
chance for survival or reproduction of sick or weak animals,
similarly in the plant kingdom, plants incapable of tolerating
conditions of dehydration due to accidental lack of water
would perish quickly, but this is not the case in human life
where deeply rooted spiritual considerations rule and control
Pathogenetics 23the way we manipulate and control our genomes, not the
reverse. There is no place for the concept of mutation-
induced natural selection in human life or in human genetics.
Instead of that, the concept of creative or artiﬁcial selection,
e.g. cloning and trials to construct new creatures with new gen-
omes, in spite of moral protestation and ethical expostulation
against its applications, will probably accomplish the major
role in inducing true evolutionary changes of the human
genome through targeted reproductive mechanisms like
pre-marital, pre-implantation and prenatal diagnosis.
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